EGFR and neoplasm: [43] demonstrated that loss of E‐cadherin along with an increased expression of vimentin and SLUG at tumor margins was related to the activation of the EGFR/ERK‐pathway through the release of EGF by cancer‐associated macrophages in the stroma.